Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: BASi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: BASi

Revenues up 2% driven by preclinical and bioanalytical services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi
 
3Q Revenues: $6.2 million (+2%)

3Q Earnings: $1.5 million (earnings were $215,000 3Q14)

YTD Revenues: $17.7 million (-2%)

YTD Earnings: $1.8 million (loss of $666,000 YTD14)

Comments: Service revenue for the quarter increased 5% to $5.0 million driven by Preclinical service and Bioanalytical analysis revenues partially offset by lower other lab services revenue. Product revenue decreased 10% to $1.1 million due to lower Analytical instrument sales.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics